BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3070420)

  • 21. Cerebral vasospasm after an intracranial aneurysmal subarachnoid hemorrhage: a nursing perspective.
    Jackson LO
    Heart Lung; 1986 Jan; 15(1):14-20. PubMed ID: 3511009
    [No Abstract]   [Full Text] [Related]  

  • 22. Vasospasm after aneurysmal subarachnoid hemorrhage: a review of pathophysiology.
    Segatore M
    Axone; 1992 Jun; 13(4):129-31. PubMed ID: 1599865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
    Haley EC; Kassell NF; Torner JC
    J Neurosurg; 1993 Apr; 78(4):537-47. PubMed ID: 8450326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prophylactic treatment of vasospasm with nimodipine in subarachnoid hemorrhage].
    Procházka M; Gazdíková K; Cigánek L; Koprdová I
    Cas Lek Cesk; 1990 Feb; 129(8):237-9. PubMed ID: 2331740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vascular spasm and cerebral ischemia after meningeal hemorrhage caused by rupture of an aneurysm].
    Van der Werf AJ
    Neurochirurgie; 1986; 32(1):1-22. PubMed ID: 3517664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aneurysmal SAH: cerebral vasospasm and early repair.
    Manifold SL
    Crit Care Nurse; 1990 Sep; 10(8):62-71. PubMed ID: 2401160
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical experiences with nimodipine treatment in patients after SAH and aneurysm surgery.
    Wroński J; Abraszko R; Berny W; Mierzwa J
    Zentralbl Neurochir; 1990; 51(1):21-3. PubMed ID: 2275300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathophysiology of cerebral vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysm].
    Jaskólski D; Zawirski M
    Pol Tyg Lek; 1988 Jun; 43(23):748-52. PubMed ID: 3070490
    [No Abstract]   [Full Text] [Related]  

  • 30. Nimodipine evoked dilation of cerebral arteries early during the development of late vasospasm in subarachnoid hemorrhage.
    Hillman J; Bynke O; Westergren H
    Neurochirurgia (Stuttg); 1991 Sep; 34(5):157-9. PubMed ID: 1745323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of cerebral vasospasm caused by the rupture of intracranial aneurysms].
    Oliver Abadal B; Sagués Gabarró F; Bartumeus Jené F
    Rev Clin Esp; 1988 Feb; 182(3):163-5. PubMed ID: 3285383
    [No Abstract]   [Full Text] [Related]  

  • 32. Cerebral vasospasm and calcium channel blockade. Nimodipine treatment in patients with aneurysmal subarachnoid hemorrhage.
    Brandt L; Ljunggren B; Säveland H; Andersson KE; Vinge E
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():151-5. PubMed ID: 3521193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium antagonists and aneurysmal subarachnoid haemorrhage.
    Lancet; 1983 Jul; 2(8342):141-3. PubMed ID: 6134985
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model.
    Hänggi D; Eicker S; Beseoglu K; Rapp M; Perrin J; Nawatny J; Turowski B; Sommer C; Steiger HJ
    Neurosurgery; 2009 Jun; 64(6):1155-9; discussion 1159-61. PubMed ID: 19487896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiology of meningeal hemorrhage caused by aneurysmal rupture (report of 600 cases)].
    Childs M; Riegel B; Jomin M; Fesard P; Robiquet P
    Agressologie; 1990 May; 31(5):253-6. PubMed ID: 2288336
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum complements as indicator for predicting vasospasm and its severity after aneurysmal subarachnoid hemorrhage.
    Kawano T; Yonekawa Y
    Nihon Geka Hokan; 1990 May; 59(3):189-97. PubMed ID: 2130781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.
    Petruk KC; West M; Mohr G; Weir BK; Benoit BG; Gentili F; Disney LB; Khan MI; Grace M; Holness RO
    J Neurosurg; 1988 Apr; 68(4):505-17. PubMed ID: 3280746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome in patients subjected to early aneurysm operation and intravenous nimodipine.
    Ljunggren BC; Brandt JL; Säveland HG
    Minerva Med; 1986 Jun; 77(24):1087-92. PubMed ID: 3725134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
    Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
    J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.